Literature DB >> 30354858

Uterine artery embolization versus hysterectomy in the treatment of refractory postpartum hemorrhage: a systematic review and meta-analysis.

ZhiRong Liu1, Yaxuan Wang2, Jingxin Yan2, Juan Li3, XinLian Liu3, LuShun Zhang3,4, Li Cheng5.   

Abstract

Introduction: We carried out a systematic review and meta-analysis to assess the safety and effectiveness of uterine artery embolization (UAE) compared with conventional hysterectomy on refractory postpartum hemorrhage (PPH).
Methods: We searched PubMed, Embase, Chinese National Knowledge Infrastructure database (CNKI), Cochrane Library, and Wanfang database through October 2017 for randomized controlled trials (RCTs) and observational studies assessing the safety and effectiveness of UAE compared with hysterectomy on refractory PPH. The main outcome measures included the blood loss, operating time, hemostatic effective rate, and length of stay.
Results: Six RCTs and nine observational studies were included in the meta-analysis, which involved 1142 women with refractory PPH. The results demonstrated that UAE was more beneficial on refractory PPH compared with hysterectomy using four scales: blood loss (WMD 893.39 mL; 95% CI: -1205.65, -581.13; p < .001); operating time (WMD -37.19 minutes; 95% CI: -44.42, -29.96; p < .001); length of stay (WMD -5.36 days; 95% CI: -5.76, -4.97; p < .001), hemostatic effective rate (OR 1.58, 95% CI: 0.80, 3.12, p = .184) .Conclusions: In the present meta-analysis, the positive findings suggest UAE has beneficial effects on refractory PPH. UAE significantly reduced blood loss, shortened the operating time, and length of stay compared with hysterectomy. And there is no difference between the UAE group and hysterectomy group in hemostatic effective rate. However, those findings should be treated with caution because of heterogeneity and potential biases.

Entities:  

Keywords:  Uterine artery embolization; hysterectomy; refractory postpartum hemorrhage

Mesh:

Year:  2018        PMID: 30354858     DOI: 10.1080/14767058.2018.1497599

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  6 in total

1.  Multidisciplinary team approach on massive postpartum pulmonary thromboembolism: experience from three cases.

Authors:  Hyeran Kang; Yoon Mi Shin; Sang Min Kim; Yook Kim; Laura Adelaide Dalla Vecchia; Kwok Ming Ho
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

Review 2.  Successful repeated uterine artery embolization in postpartum hemorrhage with disseminated intravascular coagulation: a case report and literature review.

Authors:  Shunya Sugai; Taro Nonaka; Kana Tamegai; Tatsuhiko Sato; Kazufumi Haino; Takayuki Enomoto; Koji Nishijima
Journal:  BMC Pregnancy Childbirth       Date:  2021-10-22       Impact factor: 3.007

3.  Efficacy and safety of prophylactic Bakri balloon tamponade after vaginal delivery in women with low-lying placenta: a retrospective cohort study.

Authors:  Hui Dong; Jie Song; Hongyan Cui; Xu Chen
Journal:  Ann Transl Med       Date:  2022-01

4.  Unexpected uterine body placenta accreta spectrum with placenta previa in a subsequent pregnancy after uterine artery embolization: a case report.

Authors:  Shunya Sugai; Kaoru Yamawaki; Kazufumi Haino; Koji Nishijima
Journal:  BMC Pregnancy Childbirth       Date:  2022-09-13       Impact factor: 3.105

5.  Analysis on clinical effects of dilation and curettage guided by ultrasonography versus hysteroscopy after uterine artery embolization in the treatment of cesarean scar pregnancy.

Authors:  Jian Qiu; Yunfeng Fu; Jiewei Xu; Xiaohong Huang; Guorong Yao; Weiguo Lu
Journal:  Ther Clin Risk Manag       Date:  2019-01-07       Impact factor: 2.423

6.  Obstetric Outcomes of Pregnancy After Uterine Artery Embolization.

Authors:  Mariko Jitsumori; Shinya Matsuzaki; Masayuki Endo; Takeya Hara; Takuji Tomimatsu; Satoko Matsuzaki; Tatsuya Miyake; Tsuyoshi Takiuchi; Aiko Kakigano; Kazuya Mimura; Eiji Kobayashi; Yutaka Ueda; Tadashi Kimura
Journal:  Int J Womens Health       Date:  2020-03-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.